Qiang Xia

9.4k total citations · 1 hit paper
264 papers, 6.4k citations indexed

About

Qiang Xia is a scholar working on Molecular Biology, Surgery and Hepatology. According to data from OpenAlex, Qiang Xia has authored 264 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 115 papers in Molecular Biology, 71 papers in Surgery and 65 papers in Hepatology. Recurrent topics in Qiang Xia's work include Organ Transplantation Techniques and Outcomes (50 papers), Liver Disease and Transplantation (38 papers) and Liver Disease Diagnosis and Treatment (25 papers). Qiang Xia is often cited by papers focused on Organ Transplantation Techniques and Outcomes (50 papers), Liver Disease and Transplantation (38 papers) and Liver Disease Diagnosis and Treatment (25 papers). Qiang Xia collaborates with scholars based in China, United States and Hong Kong. Qiang Xia's co-authors include Dongwei Xu, Xiaoni Kong, Jianjun Zhang, Kang He, Ping Wan, Xi‐Dai Long, Hailong Wu, Ning Xu, Mingxuan Feng and Min Xu and has published in prestigious journals such as Chemical Reviews, Advanced Materials and Nature Communications.

In The Last Decade

Qiang Xia

246 papers receiving 6.4k citations

Hit Papers

Hepatocellular carcinoma: signaling pathways and therapeu... 2025 2026 2025 20 40 60

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qiang Xia China 44 3.5k 1.6k 1.1k 1.1k 1.1k 264 6.4k
Xiangdong Wang China 47 3.3k 0.9× 992 0.6× 886 0.8× 1.3k 1.2× 1.0k 1.0× 246 7.6k
Xueying Sun China 48 3.4k 1.0× 1.7k 1.1× 561 0.5× 633 0.6× 833 0.8× 187 6.8k
Shuichi Kaneko Japan 42 3.2k 0.9× 1.1k 0.7× 1.7k 1.5× 822 0.7× 2.3k 2.2× 191 7.1k
Frank Dombrowski Germany 42 2.8k 0.8× 1.3k 0.9× 967 0.9× 1.4k 1.3× 1.2k 1.2× 157 5.9k
Dean Tian China 40 2.8k 0.8× 1.4k 0.9× 519 0.5× 496 0.5× 823 0.8× 183 5.2k
Yutaka Kohgo Japan 44 2.9k 0.8× 1.0k 0.6× 647 0.6× 1.0k 0.9× 1.5k 1.4× 243 7.4k
Fiona Oakley United Kingdom 41 2.2k 0.6× 843 0.5× 1.7k 1.5× 798 0.7× 2.2k 2.1× 105 6.0k
Jianping Gong China 36 1.8k 0.5× 727 0.5× 651 0.6× 1.1k 1.0× 1.1k 1.1× 256 4.9k
Beicheng Sun China 50 4.7k 1.4× 3.0k 1.9× 1.1k 1.0× 921 0.8× 1.5k 1.4× 177 8.7k
Yanning Liu China 27 3.3k 1.0× 1.6k 1.0× 453 0.4× 538 0.5× 992 0.9× 73 6.2k

Countries citing papers authored by Qiang Xia

Since Specialization
Citations

This map shows the geographic impact of Qiang Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiang Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiang Xia more than expected).

Fields of papers citing papers by Qiang Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiang Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiang Xia. The network helps show where Qiang Xia may publish in the future.

Co-authorship network of co-authors of Qiang Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Qiang Xia. A scholar is included among the top collaborators of Qiang Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiang Xia. Qiang Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Liu, Yanfeng, Fan Wang, Guoquan Yan, et al.. (2024). CPT1A loss disrupts BCAA metabolism to confer therapeutic vulnerability in TP53-mutated liver cancer. Cancer Letters. 595. 217006–217006. 18 indexed citations
3.
Wang, Chenchen, et al.. (2024). Macroscopic inhibition of DNA damage repair pathways by targeting AP-2α with LEI110 eradicates hepatocellular carcinoma. Communications Biology. 7(1). 342–342. 2 indexed citations
5.
Ji, Suping, Rui Sun, Wenjuan Wang, & Qiang Xia. (2023). Preparation, characterization, and evaluation of tamarind seed polysaccharide-carboxymethylcellulose buccal films loaded with soybean peptides-chitosan nanoparticles. Food Hydrocolloids. 141. 108684–108684. 30 indexed citations
6.
Wang, Yizhong, Yanming Lu, Hui Hu, et al.. (2023). Altered gut microbiota composition in children and their caregivers infected with the SARS-CoV-2 Omicron variant. World Journal of Pediatrics. 19(5). 478–488. 5 indexed citations
7.
Zhang, Mengwei, Jinkai Liu, & Qiang Xia. (2023). Role of gut microbiome in cancer immunotherapy: from predictive biomarker to therapeutic target. Experimental Hematology and Oncology. 12(1). 84–84. 70 indexed citations
8.
Lyu, Zhuwan, Bingyuan Huang, Jun Zhang, et al.. (2023). Suppression of YTHDF2 attenuates autoimmune hepatitis by expansion of myeloid-derived suppressor cells. Journal of Autoimmunity. 135. 102993–102993. 16 indexed citations
9.
Wu, Yan, Huike Jiao, Kang He, et al.. (2022). Ubiquitin ligase E3 HUWE1/MULE targets transferrin receptor for degradation and suppresses ferroptosis in acute liver injury. Cell Death and Differentiation. 29(9). 1705–1718. 98 indexed citations
10.
Zhao, Zhenjun, Helge Gad, Carlos Benitéz‐Buelga, et al.. (2021). NEIL3 Prevents Senescence in Hepatocellular Carcinoma by Repairing Oxidative Lesions at Telomeres during Mitosis. Cancer Research. 81(15). 4079–4093. 20 indexed citations
11.
Wang, Tianyi, Mingxuan Feng, Xinyu Wan, et al.. (2021). Successful Treatment of Pediatric Refractory Burkitt Lymphoma PTLD after Liver Transplantation using Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy. Cell Transplantation. 30. 2139989353–2139989353. 19 indexed citations
12.
Cai, Jie, Xuehua Sun, Han Guo, et al.. (2020). Non-metabolic role of UCK2 links EGFR-AKT pathway activation to metastasis enhancement in hepatocellular carcinoma. Oncogenesis. 9(12). 103–103. 27 indexed citations
13.
Liu, Yuan, Tianfei Lu, Cheng Zhang, et al.. (2019). Pituitary Adenylate Cyclase-activating Polypeptides Prevent Hepatocyte Damage by Promoting Yes-associated Protein in Liver Ischemia-Reperfusion Injury. Transplantation. 103(8). 1639–1648. 14 indexed citations
14.
Hou, Jiajie, He Zhang, Jun Liu, et al.. (2019). YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma. Molecular Cancer. 18(1). 268 indexed citations
15.
Shen, Chuan, Zaili Zhang, Yuxiao Deng, et al.. (2019). Effectiveness of tigecycline in the treatment of infections caused by carbapenem‐resistant gram‐negative bacteria in pediatric liver transplant recipients: A retrospective study. Transplant Infectious Disease. 22(1). e13199–e13199. 7 indexed citations
16.
Zhang, Yanli, Qing Li, Fang Fang, et al.. (2018). SPON2 Promotes M1-like Macrophage Recruitment and Inhibits Hepatocellular Carcinoma Metastasis by Distinct Integrin–Rho GTPase–Hippo Pathways. Cancer Research. 78(9). 2305–2317. 119 indexed citations
17.
Li, Meng, Min Xu, Jichang Li, et al.. (2018). Alda-1 Ameliorates Liver Ischemia-Reperfusion Injury by Activating Aldehyde Dehydrogenase 2 and Enhancing Autophagy in Mice. Journal of Immunology Research. 2018. 1–14. 18 indexed citations
18.
Yang, Xiaomei, Xiaoyan Cao, Ping He, et al.. (2018). Overexpression of Rac GTPase Activating Protein 1 Contributes to Proliferation of Cancer Cells by Reducing Hippo Signaling to Promote Cytokinesis. Gastroenterology. 155(4). 1233–1249.e22. 90 indexed citations
19.
20.
Long, Xi‐Dai, Zhifeng Xi, Yun Ma, et al.. (2014). MicroRNA-24 Modulates Aflatoxin B1-Related Hepatocellular Carcinoma Prognosis and Tumorigenesis. BioMed Research International. 2014. 1–13. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026